From: Abstracts of the ICARE 2022 76th SIAARTI National Congress
Characteristic | Total patients (N=65) |
---|---|
Age, years | 83 ± 8 |
Height, cm | 164 ± 7 |
Weight, Kg | 65 ± 12 |
Body mass index, Kg/m2 | 24 ± 4 |
Female | 47 (72) |
Male | 18 (28) |
Level of education: | |
 None | 9 (14) |
 Elementary school diploma | 17 (26) |
 Lower secondary school diploma | 9 (14) |
 High school diploma | 22 (34) |
 Degree | 8 (12) |
ASA status: | |
 1 | 2 (3) |
 2 | 25 (38) |
 3 | 36 (56) |
 4 | 2 (3) |
Medical history: | |
 Cardiovascular diseases | 50 (77) |
  Permanent atrial fibrillation | 11 (17) |
  Previous coronary artery revascularization | 5 (7) |
 Chronic kidney disease | 6 (9) |
 Diabetes | 8 (12) |
 Hepatic diseases | 2 (3) |
 Neurologic diseases | 20 (31) |
  Major depression | 4 (6) |
  Muscular dystrophy | 1 (1) |
  Parkinson disease | 2 (3) |
  Previous stroke/cerebral hemorrhage | 4 (6) |
  Vascular dementia | 9 (14) |
 Pulmonary diseases | 19 (29) |
 Severe hearing loss | 15 (23) |
Medical history: | |
 β-blockers | 19 (29) |
 Angiotensin-converting enzyme inhibitors | 39 (60) |
 Anticoagulants/Antiplatelet agents | 31 (47) |
 Diuretics | 25 (38) |
 Statins | 19 (29) |
 Oral hypoglicemic agents | 4 (6) |
 Insulin | 2 (3) |
Type of fracture: | |
 Head/Neck femoral fracture | 30 (46) |
 Pertrochanteric femoral fracture | 35 (54) |
Type of surgery: | |
 General anesthesia | 30 (46) |
 Subarachnoid analgesia | 35 (54) |
 Suprainguinal fascia iliaca/femoral nerve block | 35 (54) |
Time from hospital arrival to surgery, hours | 41 (34-48) |
Hospital length of stay, days | 9 (7-12) |
30-day mortality | 4 (6) |
ADL score | 5 ± 1 |
IADL score | 5 ± 3 |
Preoperative MoCA test score of patients who developed POD (N=5) | 21 ± 4 |
MoCA test score at discharge of patients who developed POD (N=5) | 19 ± 6 |
Preoperative MoCA test score of patients who did not develop POD (N=38) | 22 ± 5 |
MoCA test score at discharge of patients who did not develop POD (N=38) | 23 ± 5 |